Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Scientific Reports (6)
Oncogene (2)
Nature Medicine (2)
Cell Death & Disease (1)
npj Vaccines (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (15)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Diseases
Endocrinology
Engineering
Gastroenterology
Genetics
Health care
Immunology
Medical research
Microbiology
Pathogenesis
Physiology
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–16 of 16 results

Advanced filters: Author: Massimo Ippolito Clear advanced filters

Fractal magmatic systems

MASSIMO CORTINI
Research19 Jul 1990
Nature

Volume: 346, P: 226
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program

Vincenza Calvaruso
Chiara Mazzarelli
Antonio Craxì
ResearchOpen Access24 Jan 2019
Scientific Reports

Volume: 9, P: 1-8
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

The SAVE-MORE phase 3 study demonstrates the efficacy of anakinra, an IL-1α/β inhibitor, in patients with COVID-19 and high serum levels of soluble plasminogen activator receptor.

Evdoxia Kyriazopoulou
Garyfallia Poulakou
Evangelos J. Giamarellos-Bourboulis
ResearchOpen Access03 Sept 2021
Nature Medicine

Volume: 27, P: 1752-1760
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection

Fiorina and colleagues document alterations in glucose metabolism in patients with COVID-19 and use continuous glucose monitoring to show that glycaemic abnormalities could still be detected 2 months after disease onset in patients who had recovered.

Laura Montefusco
Moufida Ben Nasr
Paolo Fiorina
Research25 May 2021
Nature Metabolism

Volume: 3, P: 774-785
Human Endometrial Stromal Cells Are Highly Permissive To Productive Infection by Zika Virus

Isabel Pagani
Silvia Ghezzi
Elisa Vicenzi
ResearchOpen Access10 Mar 2017
Scientific Reports

Volume: 7, P: 1-9
Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Evdoxia Kyriazopoulou
Garyfallia Poulakou
Evangelos J. Giamarellos-Bourboulis
Amendments and CorrectionsOpen Access08 Oct 2021
Nature Medicine

Volume: 27, P: 1850
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine

Chiara Agrati
Concetta Castilletti
Eliana Specchiarello
ResearchOpen Access23 Apr 2022
Scientific Reports

Volume: 12, P: 1-5
Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome

Alessandra Sacchi
Germana Grassi
Chiara Agrati
ResearchOpen Access27 Oct 2020
Cell Death & Disease

Volume: 11, P: 1-9
Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression

Roberta Visconti
Janete Cerutti
Alfredo Fusco
Research16 Oct 1997
Oncogene

Volume: 15, P: 1987-1994
Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo

Sabrina Battista
Filomena de Nigris
Alfredo Fusco
Research28 Jul 1998
Oncogene

Volume: 17, P: 377-385
Proton boron capture therapy (PBCT) induces cell death and mitophagy in a heterotopic glioblastoma model

Proton boron capture therapy (PBCT) in a preclinical glioblastoma model exhibits increased therapeutic effectiveness with an increased cell death and mitophagy, supporting its use as a scalable strategy to treat glioblastoma.

Francesco Paolo Cammarata
Filippo Torrisi
Giacomo Cuttone
ResearchOpen Access08 Apr 2023
Communications Biology

Volume: 6, P: 1-12
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

Munib Mesinovic
Xin Ci Wong
David Zucman
ResearchOpen Access16 Jul 2024
Scientific Reports

Volume: 14, P: 1-43
Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia

Alessandra Vergori
Patrizia Lorenzini
Sara Zito
ResearchOpen Access31 May 2021
Scientific Reports

Volume: 11, P: 1-10
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results

Chiara Agrati
Concetta Castilletti
Stefania Capone
ResearchOpen Access24 Sept 2022
npj Vaccines

Volume: 7, P: 1-11
Genetic and environmental influences on height from infancy to early adulthood: An individual-based pooled analysis of 45 twin cohorts

Aline Jelenkovic
Reijo Sund
Karri Silventoinen
ResearchOpen Access23 Jun 2016
Scientific Reports

Volume: 6, P: 1-13
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

Ali Abbas
Sheryl Ann Abdukahil
Luis Felipe Reyes
ResearchOpen Access30 Jul 2022
Scientific Data

Volume: 9, P: 1-22